InvestorsHub Logo

ThePrestige1

05/27/20 5:17 PM

#66996 RE: Deetew #66995

It seems to me like they are trying to sweep the market effect of the Canadian study under the rug.



No doubt.

SpaceLady

05/27/20 6:04 PM

#66997 RE: Deetew #66995

I absolutely agree. The solution is simple, if CBD works, there would be a watershed pharma will not be able to stop.

Smooth_Legend

05/28/20 2:59 AM

#67002 RE: Deetew #66995

Shorts main thesis from past years has been that CBD is a placebo.

From this article we learn that full spectrum CBD is a possible treatment and not the CBD isolate.

It's cure vs. treatment and isolate vs. full spectrum argument.

Somehow this justifies to short companies that could provide products for treatments, which have shown to reduce virus’s entry points by up to 70%.

What's the short thesis now, people won't spend money on treatments, they will spend it only for the cure?

Back in the day it was believed that treatment would bring more revenue vs. the cure, was something decided differently by Forbes and I didn 't get the memo?